𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A New Drug Design Targeting the Adenosinergic System for Huntington's Disease

✍ Scribed by Huang, Nai-Kuei; Lin, Jung-Hsin; Lin, Jiun-Tsai; Lin, Chia-I; Liu, Eric Minwei; Lin, Chun-Jung; Chen, Wan-Ping; Shen, Yuh-Chiang; Chen, Hui-Mei; Chen, Jhih-Bin; Lai, Hsing-Lin; Yang, Chieh-Wen; Chiang, Ming-Chang; Wu, Yu-Shuo; Chang, Chen; Chen, Jiang-Fan; Fang, Jim-Min; Lin, Yun-Lian; Chern, Yijuang; Manzoni, Olivier Jacques


Book ID
120454446
Publisher
Public Library of Science
Year
2011
Tongue
English
Weight
749 KB
Volume
6
Category
Article
ISSN
1932-6203

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A new probe for targeting drug delivery
✍ Zhengwen Yu; Bochu Wang; Jing Sui; Yingzhu Feng; Chao Zheng πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 113 KB
Particle shape: A new design parameter f
✍ Padma V. Devarajan; Anil B. Jindal; Rajesh R. Patil; Fernaz Mulla; Rajiv V. Gaik πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 381 KB

The role of particle size and surface modification on biodistribution of nanocarriers is widely reported. We report for the first time the role of nanoparticle shape on biodistribution. Our study demonstrates that irregular shaped polymer lipid nanoparticles (LIPOMER) evade kupffer cells and localiz

A novel target for Huntington's disease:
✍ Bodai, LΓ‘szlΓ³ (author);Marsh, J. Lawrence (author) πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 300 KB πŸ‘ 1 views

## Abstract Activating the ERK pathway (extracellular signal‐regulated kinase pathway) has proven beneficial in several models of Huntington's disease (HD), and drugs that are protective in HD models have recently been found to activate ERK. Thus, the ERK cascade may be a potential target for thera